FibroGen (FGEN) announced the appointment of David DeLucia to CFO, effective December 16, 2024. The company previously announced that Juan Graham would step down on December 15, 2024. Reporting to CEO, Thane Wettig, DeLucia will lead and oversee FibroGen’s global finance organization. He has most recently served as FibroGen’s Vice President, Head of Corporate Financial Planning and Analysis, Investor Relations, and Treasury.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FGEN:
Questions or Comments about the article? Write to editor@tipranks.com